Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Basel Haffar"'
Autor:
Assad Soweid, Jean El Cheikh, Mohammad Husni, Basel Haffar, Alaa Sharara, Jana Al-Hashash, Radwan Massoud, Ali Bazarbachi, Yasser H. Shaib, Fady Daniel, Lara Hassoun, Kassem Barada
Publikováno v:
Current Research in Translational Medicine. 67:16-19
Background Gastrointestinal (GI) graft versus host disease (GVHD) occurs in up to 40% of patients undergoing allogenic hematopoietic stem cell transplantation (HSCT). However, the optimal endoscopic approach is still unclear and the area of the GI tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ca665d25cb777dd63b1da970c3af40
https://doi.org/10.1016/j.retram.2018.08.001
https://doi.org/10.1016/j.retram.2018.08.001
Autor:
Radwan Massoud, Hazem I. Assi, Rami Mahfouz, Basel Haffar, Jean El-Cheikh, Ammar Zahreddine, Nour Moukalled, Ali Bazarbachi
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:368-374
Introduction The optimal intensity of myeloablation with a reduced-toxicity conditioning regimen to decrease relapse rate after allogeneic stem-cell transplantation without increasing transplant-related mortality (TRM) has not been well established.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74a85e757f1c877e24b46f85fe18f39
https://doi.org/10.1016/j.clml.2018.02.016
https://doi.org/10.1016/j.clml.2018.02.016
Publikováno v:
Bone Marrow Transplantation. 52:1187-1190
Dynamics of molecular response in AML patients with NPM1 and FLT3 mutations undergoing allogeneic stem cell transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14faebc15f3a7932269d09c0f70394a0
https://doi.org/10.1038/bmt.2017.82
https://doi.org/10.1038/bmt.2017.82
Autor:
Basel Haffar, Ali Youssef, Radwan Massoud, Mohamed A. Kharfan-Dabaja, Ali Bazarbachi, Elie Fares, Jean El Cheikh, Ahmad Ibrahim, Tamima Jisr, Rami Mahfouz, Anas Mougharbel
Publikováno v:
Leukemia & Lymphoma. 58:2745-2747
Although considered as one of the most curable adult malignancies, Hodgkin lymphoma (HL) becomes life threatening when refractory to primary induction or when it relapses after remission, leading t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5efca8aed7cd4fb668905604f90d9d9
https://doi.org/10.1080/10428194.2017.1307362
https://doi.org/10.1080/10428194.2017.1307362
Autor:
Mohamed A. Kharfan-Dabaja, Rami Mahfouz, Anas Mougharbel, Basel Haffar, Ali Bazarbachi, J. El Cheikh, T. Jisr, I Abudalle, Ali Ibrahim, Radwan Massoud
Publikováno v:
Bone marrow transplantation. 52(7)
Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9255eb67bf43413fc8526b76cba8288
https://pubmed.ncbi.nlm.nih.gov/28394366
https://pubmed.ncbi.nlm.nih.gov/28394366
Autor:
Nabila Kreidieh, Mohamed A. Kharfan-Dabaja, Radwan Massoud, Rami Mahfouz, Elie Fares, Basel Haffar, Souha S. Kanj, Ali Bazarbachi, Aline El Zakhem, Jean El Cheikh, Rita Assi, Maya Charafeddine
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 95
Background Cytomegalovirus reactivation is often diagnosed in allogeneic hematopoietic cell transplant recipients and therefore could lead to CMV-related disease, involving many organs in these immunocompromised patients. In contrast, few studies inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c016cf5623b0d1a9025afdfbf721b84
https://pubmed.ncbi.nlm.nih.gov/28843110
https://pubmed.ncbi.nlm.nih.gov/28843110
Autor:
Jean El Cheikh, Rana Salem, Ali Bazarbachi, Haidar El Darsa, Charelle Salem, Basel Haffar, Yolla Haibe
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S189-S190
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a427898ee23df01a1b9cb89b6e78e9
https://doi.org/10.1016/j.clml.2018.07.027
https://doi.org/10.1016/j.clml.2018.07.027
Autor:
Radwan Massoud, Basel Haffar, Ali Bazarbachi, Nour Moukalled, Raban Heller, Charbel F Matar, Jean El-Cheikh
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S310-S311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::978cdfde1c8b18e7477e927f12cab761
https://doi.org/10.1016/j.clml.2018.07.275
https://doi.org/10.1016/j.clml.2018.07.275
Autor:
Basel Haffar, Jean El-Cheikh, Rita Nehme, Ali Bazerbachi, Radwan Massoud, Nour Moukalled, Ammar Zahreddine
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S311-S312
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::905ee901d344b945894787c3fb032a54
https://doi.org/10.1016/j.clml.2018.07.277
https://doi.org/10.1016/j.clml.2018.07.277
Autor:
Ali Bazarbachi, Rola El Sayed, Basel Haffar, Radwan Massoud, Yolla Haibe, Nebeela Kreidieh, Nour Moukalled, Jean El Cheikh, Ammar Zahreddine, Rana Salem
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:S311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea9ea5a362774442a830feab34f5d90d
https://doi.org/10.1016/j.clml.2018.07.276
https://doi.org/10.1016/j.clml.2018.07.276